Skip to main content
Log in

The Authors’ Reply

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gandjour A. Assessing the value of a future study [letter]. Pharmacoeconomics 2008; 26 (10): 891–2

    Article  PubMed  Google Scholar 

  2. Shavit O, Leshno M, Goldberger A, et al. It’s time to choose the study design!: net benefit analysis of alternative study designs to acquire information for evaluation of health technologies. Pharmacoeconomics 2007; 25 (11): 903–11

    Article  PubMed  Google Scholar 

  3. Hunink M, Glasziou P, Siegel J, et al. Decision making in health and medicine: integrating evidence and values. 1st ed. Cambridge: Cambridge University Press, 2001

    Google Scholar 

  4. Folland S, Goodman A, Stano M. Demand for health capital: the economics of health and health care. 5th ed. Upper Saddle River (NJ): Pearson Education, 2007: 137–152

    Google Scholar 

  5. Zivin JG. Cost-effectiveness analysis with risk aversion. Health Econ 2001; 10 (6): 499–508

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shavit, O., Leshno, M., Goldberger, A. et al. The Authors’ Reply. Pharmacoeconomics 26, 892–894 (2008). https://doi.org/10.2165/00019053-200826100-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200826100-00009

Keywords

Navigation